Stephanie Holley

Sanofi (France)

Papers

1

Total Citations

2

H-Index

1

About

Dr. Stephanie Holley is a leading figure in the automation of high-throughput biochemical workflows, with a primary focus on enhancing efficiency in pharmaceutical and biotechnology research. Her most impactful work centers on the integration of modular robotic platforms to streamline the design-make-test-analyze (DMTA) cycle, a critical bottleneck in drug discovery. In her landmark 2024 study, Dr. Holley demonstrated how automating multiplex biochemical assays can dramatically reduce cycle time while simultaneously generating rich, multiparameter data in a single robotic run. This innovation directly addresses the industry's urgent need for faster, more productive compound screening. With 2 citations to date, her work is gaining traction as a foundational reference for labs seeking to modernize their assay pipelines. Dr. Holley’s contributions are particularly notable for bridging the gap between complex automation engineering and practical, scalable laboratory solutions, positioning her as a key architect of next-generation, high-efficiency research environments.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Automation of multiplex biochemical assays to enhance productivity and reduce cycle time using a modular robotic platform
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Sanofi (France)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago